UNSPSC 41202030: Herpes simplex virus serological assays

In this classification, Herpes simplex virus serological assays are devices used in test to identify specific Herpes simplex virus serological assays antibodies in serum. US FDA regulates Herpes simplex virus serological assays under 21 CFR 866.3305 and under FDA product code GQN.

UNSPSC 41202030 Herpes simplex virus serological assays is a Commodity code that covers HIV and syphilis diagnostic testing kits, reagents, and related laboratory screening services procured by state health departments, county criminal justice agencies, and municipal public health programs. The code encompasses rapid point-of-care test kits (such as Abbott Determine HIV 1/2 Ag/Ab Combo tests), automated screening assays integrated with laboratory information systems, confirmatory testing methodologies including LC/MS/MS and GC/MS, reagent consumables and calibrator kits for high-volume analyzer platforms, and specimen collection and testing logistics including electronic result reporting. Recent solicitations show state and local buyers using the code for both routine supply procurement and emergency sole-source acquisitions driven by critical public health operations.

The issuing-body mix includes state departments of public health (Illinois Department of Public Health, Texas Department of Criminal Justice), county criminal justice and community supervision departments (Collin County, Texas), and municipal public health agencies (City of Austin). Illinois and Texas account for the most recent activity. Representative opportunities include the Collin County Community Supervision and Corrections Department RFP 2026-327 for offender specimen collection and drug testing services—including specimen collection at two sites, immunoassay screening with confirmatory testing, and alternative methodologies (oral fluid and hair)—with approximately 25,031 annual tests estimated at $600,000 over two years with three optional one-year renewals, proposals due July 23, 2026; the City of Austin IFB 9100AAM1023 for rapid HIV test kits (Abbott Determine HIV 1/2 Ag/Ab Combo) supporting the Austin Public Health Program, with bids due July 17, 2026; and the Illinois Department of Public Health IFB for a five-year contract for HIV, syphilis, and hepatitis screening assays and fully automated instrumentation in Jackson County, with annual volumes of approximately 13,200 HIV tests and a March 16, 2026 bid deadline. Two Abbott Laboratories sole-source emergency procurements by IDPH (February and May 2026) totaling $38,079.50 reflect the regulatory constraints and sole-manufacturer dependencies that characterize this market.